LON:REDX - Redx Pharma Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started GBX 8.60 0.00 (0.00 %) (As of 09/21/2018 04:00 PM ET)Previous CloseGBX 8.60Today's RangeGBX 8.28 - GBX 8.6852-Week RangeGBX 12 - GBX 43Volume19,077 shsAverage Volume67,755 shsMarket Capitalization£14.09 millionP/E RatioN/ADividend YieldN/ABetaN/A Company ProfileDiscussionChartEarnings HistoryInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Redx Pharma Plc operates as a drug discovery and development company in the United Kingdom. It discovers and develops small molecule drugs for treating cancer and fibrosis. The company is developing RXC004, a porcupine inhibitor for the treatment of pancreatic, biliary, and gastric cancers, as well as melanoma; Pan-RAF inhibitor for colorectal cancer; and SHP2, a protein-tyrosine phosphatase for receptor tyrosine kinase signaling in cancer cells. It is also developing ROCK inhibitor for treating inflammatory bowel disease related fibrosis; Porcupine, a drug for idiopathic pulmonary fibrosis (IPF), non-alcoholic steatohepatitis (NASH), and liver fibrosis; and ROCK2, a Rho-associated protein kinase 2 inhibitor for the treatment of diabetic nephropathy, and IPF and NASH/liver fibrosis. The company has research collaboration with AstraZeneca. Redx Pharma Plc was founded in 2010 and is based in Macclesfield, the United Kingdom. Receive REDX News and Ratings via Email Sign-up to receive the latest news and ratings for REDX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry Biotechnology Sub-IndustryN/A SectorMedical SymbolLON:REDX CUSIPN/A Webredxpharma.com Phone+44-151-7064747 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net Margins40.10% Return on Equity294.97% Return on Assets123.97% Miscellaneous EmployeesN/A Outstanding Shares126,480,000Market Cap£14.09 million Redx Pharma (LON:REDX) Frequently Asked Questions What is Redx Pharma's stock symbol? Redx Pharma trades on the London Stock Exchange (LON) under the ticker symbol "REDX." How were Redx Pharma's earnings last quarter? Redx Pharma PLC (LON:REDX) announced its quarterly earnings data on Wednesday, May, 30th. The company reported ($3.60) earnings per share (EPS) for the quarter. Redx Pharma had a net margin of 40.10% and a return on equity of 294.97%. View Redx Pharma's Earnings History. Who are some of Redx Pharma's key competitors? Some companies that are related to Redx Pharma include BELLUS Health (BLU), Medicenna Therapeutics (MDNA), Destiny Pharma (DEST), NovaBay Pharmaceuticals (NBY), Rexahn Pharmaceuticals (RNN), Abzena (ABZA), OptiBiotix Health (OPTI), Scancell (SCLP), Synthetic Biologics (SYN), DiaMedica Therapeutics (DMA), Antibe Therapeutics (ATE), Biopharmx (BPMX), Realm Therapeutics (RLM), Ceapro (CZO) and Nuvo Pharmaceuticals (NRI). Who are Redx Pharma's key executives? Redx Pharma's management team includes the folowing people: Ms. Lisa Mary Whewell Anson, CEO & Director (Age 49)Mr. Dominic Nicholas Jackson, CFO & Exec. Director (Age 37)Dr. Richard Armer, Chief Scientific OfficerMr. Nicholas Adams BSc, Chief Bus. Officer (Age 54)Dr. Andrew Saunders, Chief Medical Officer (Age 53) Has Redx Pharma been receiving favorable news coverage? News articles about REDX stock have trended somewhat positive this week, Accern Sentiment reports. The research firm ranks the sentiment of media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Redx Pharma earned a news and rumor sentiment score of 0.18 on Accern's scale. They also assigned media coverage about the company an impact score of 46.57 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next few days. View Recent Headlines for Redx Pharma. How do I buy shares of Redx Pharma? Shares of REDX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Redx Pharma's stock price today? One share of REDX stock can currently be purchased for approximately GBX 8.60. How big of a company is Redx Pharma? Redx Pharma has a market capitalization of £14.09 million. How can I contact Redx Pharma? Redx Pharma's mailing address is Block 33, Mereside,, Alderley Park, MACCLESFIELD, SK10 4TG, United Kingdom. The company can be reached via phone at +44-151-7064747. MarketBeat Community Rating for Redx Pharma (LON REDX)Community Ranking: 3.0 out of 5 ( )Outperform Votes: 110 (Vote Outperform)Underperform Votes: 72 (Vote Underperform)Total Votes: 182MarketBeat's community ratings are surveys of what our community members think about Redx Pharma and other stocks. Vote "Outperform" if you believe REDX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe REDX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 9/21/2018 by MarketBeat.com StaffFeatured Article: What is the Ex-Dividend Date in Investing?